<div class="headers"><div>Supplementary figure S3: DAS28 Early vs Late Disease (APPEAL + LARA). (B)  >2 years disease duration population BL: Baseline; ETN: etanercept; csDMARDs: conventional synthetic DMARDs. N=350 for ETN + MTX. N=181 for DMARDs</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<tbody>
<tr style='border-top: 2px solid grey;'>
<td style='border-top: 2px solid grey; text-align: left;'><p class="">Supplementary figure S3: DAS28 Early vs Late Disease (APPEAL + LARA). (B)  >2 years disease duration population </p></td>
</tr>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'><p class="">BL: Baseline; ETN: etanercept; csDMARDs: conventional synthetic DMARDs. N=350 for ETN + MTX. N=181 for DMARDs</p></td>
</tr>
</tbody>
</table>
